US 8501750
Heterocyclic compound and use thereof
granted A61PA61P1/02A61P1/04
Quick answer
US patent 8501750 (Heterocyclic compound and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Aug 06 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 01 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61P, A61P1/02, A61P1/04, A61P1/08, A61P1/12